+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Kidney Function Tests Market by Test Type, Technology, End User, Sample Type, Distribution Channel - Global Forecast to 2030- Product Image
Kidney Function Tests Market by Test Type, Technology, End User, Sample Type, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Kidney Function Tests Market by Test Type, Technology, End User, Sample Type, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716460
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Kidney Function Tests Market grew from USD 965.68 million in 2024 to USD 1.02 billion in 2025. It is expected to continue growing at a CAGR of 6.35%, reaching USD 1.39 billion by 2030.

Unveiling the Essentials of Kidney Function Testing

Kidney function tests have emerged as indispensable tools in clinical practice, enabling early detection of renal impairment and guiding therapeutic decisions. In recent years, advances in assay sensitivity and specificity have transformed routine testing protocols, providing clinicians with more accurate metrics to monitor patient health. This introduction outlines the fundamental role of these diagnostic evaluations in safeguarding renal function, improving patient outcomes, and reducing long-term healthcare costs.

Through a combination of biochemical markers and cutting-edge technologies, these tests offer comprehensive insights into glomerular filtration efficiency, tubular integrity, and the presence of microalbuminuria. By integrating these measures, practitioners can detect subtle shifts in renal performance before overt symptoms manifest. This proactive approach supports timely intervention and personalized treatment planning, reaffirming the critical importance of standardized kidney function testing in modern healthcare.

Identifying Transformative Shifts Reshaping the Market Landscape

Over the past decade, the kidney function testing landscape has witnessed a remarkable convergence of molecular diagnostics and automation technologies. Assay developers have introduced high-throughput platforms that streamline sample processing and expedite turnaround times. Simultaneously, the incorporation of artificial intelligence and data analytics has enabled more robust interpretation of longitudinal patient data, uncovering patterns that inform risk stratification and therapeutic optimization.

In parallel, the rise of home-based monitoring solutions has empowered patients to participate actively in their health management. Portable devices now provide near-clinical accuracy in measuring key biomarkers, facilitating remote care models and reducing the burden on centralized laboratories. These transformative shifts are redefining the diagnostic journey, enhancing accessibility, and setting new performance benchmarks in renal healthcare.

Assessing the Cumulative Effects of US Tariff Changes in 2025

In 2025, updated tariff schedules introduced by the United States have exerted a tangible influence on the kidney function testing market. Increased duties on imported reagents and instrumentation have elevated input costs, prompting suppliers and distributors to reevaluate pricing strategies. The cascading effect has been felt across supply chains as manufacturers seek to mitigate margin pressures through supplier diversification and localized production investments.

Concurrently, end users have responded by consolidating procurement and negotiating volume-based agreements to offset incremental expenses. Some regional players have explored domestic alternatives to minimize exposure to cross-border duties, while others have accelerated the adoption of high-value immunoassay platforms to justify premium pricing. Overall, these policy shifts have underscored the need for agile operational models, robust cost-control measures, and proactive engagement with regulatory authorities to maintain market momentum.

Unlocking Segmentation Insights Across Diverse Test Parameters

Segmenting the kidney function testing market reveals nuanced opportunities and evolving demands across multiple dimensions. When evaluating test types, assessments of blood urea nitrogen, cystatin C, glomerular filtration rate, microalbuminuria, and serum creatinine uncover distinct clinical preferences and reagent cost profiles. This variation informs targeted product design and portfolio optimization initiatives.

Technological segmentation highlights a dynamic interplay between electrochemiluminescence, fluorescence polarization, immunoassay variants including CLIA, ELISA, and FIA, as well as spectrophotometry techniques such as colorimetric and reflectance methods. Each technology group commands unique infrastructure requirements, throughput capabilities, and analytical performance metrics, driving differentiated adoption patterns among laboratory networks and point-of-care settings.

End user segmentation spans diagnostic laboratories, home care environments, hospitals, and specialized kidney care clinics. The diagnostic laboratory segment demands high-volume automated workflows, while home-based monitoring emphasizes portability and ease of use. Hospitals and kidney care clinics prioritize integrated data management and multi-marker panels to support comprehensive patient evaluations.

Sample type analysis contrasts serum-based assays with urine-based detections, each with its own pre-analytical considerations and sample stability requirements. Finally, distribution channel insights differentiate established offline networks from emerging online platforms, reflecting digital transformation trends and shifting buyer preferences. This comprehensive segmentation framework underpins tailored marketing strategies and informs resource allocation across the value chain.

Mapping Regional Dynamics Driving Global Market Growth

Understanding regional dynamics is essential for aligning market entry strategies and allocation of development resources. In the Americas, advanced reimbursement frameworks and high awareness of chronic kidney disease drive robust demand for next-generation biomarkers and point-of-care diagnostics. Market players here focus on enhancing assay accuracy and expanding service offerings in both urban and rural settings.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and public sector investments in preventive care are elevating the standard of renal diagnostics. Manufacturers are forging strategic partnerships to navigate diverse regulatory regimes and capitalise on emerging telehealth initiatives that support decentralized testing.

The Asia-Pacific region presents a rapidly evolving landscape marked by rising prevalence of diabetes and hypertension, which fuels demand for routine kidney function screening. Local production capabilities are expanding to address cost sensitivities, while collaborative agreements between multinational firms and regional distributors facilitate broader access to advanced platforms. These regional insights guide targeted R&D investments, distribution strategies, and stakeholder engagement plans.

Revealing Strategic Moves of Leading Industry Players

Leading life science companies are deploying multifaceted strategies to reinforce their positions in the kidney function testing market. One global diagnostics firm has accelerated the integration of immunoassay and automation technologies, leveraging recent acquisitions to broaden its portfolio and streamline reagent supply. Another key player has invested in advanced reagent formulations designed to enhance assay stability and reduce cold chain dependencies, thereby lowering logistical costs for remote clinics and developing markets.

Strategic collaborations between instrumentation manufacturers and software providers have resulted in end-to-end solutions offering seamless data connectivity, predictive analytics, and enhanced laboratory efficiency. In parallel, several companies have expanded their geographic footprint through joint ventures and distribution partnerships, targeting high-growth markets in Asia and Latin America. Together, these initiatives underscore a competitive landscape characterized by both technological innovation and strategic consolidation.

Crafting Actionable Strategies for Market Leadership

Industry leaders should prioritize innovation in immunoassay sensitivity and automation compatibility to differentiate their offerings. Investing in modular platforms that accommodate both high-throughput central lab applications and decentralized point-of-care testing will address evolving customer needs and drive revenue diversification. Cultivating strategic partnerships with laboratory networks and telehealth providers can facilitate seamless integration of diagnostic workflows and expand service reach.

A robust supply chain resilience program is imperative to mitigate the impacts of tariff volatility and logistical disruptions. Establishing regional manufacturing hubs and multi-sourcing arrangements will enhance operational flexibility. Equally, harnessing digital marketing channels and e-commerce platforms can increase market penetration, particularly in segments where direct procurement models are gaining traction. By executing these targeted actions, market leaders can fortify their competitive edge and capture sustained growth.

Detailing a Rigorous Approach to Research Integrity

The research underpinning this executive summary combined qualitative insights from in-depth discussions with clinical experts, laboratory directors, and policy advisors with a thorough review of industry white papers, regulatory guidelines, and peer-reviewed publications. Data triangulation techniques were employed to validate market observations, ensuring consistency across multiple sources.

Secondary research included analysis of corporate annual reports, product launch announcements, and patent filings to track technology advancement and strategic alliances. Throughout the study, rigorous data hygiene practices maintained the integrity of findings, while an iterative validation process with subject matter experts safeguarded against bias. This methodological rigor guarantees that the insights presented here reflect a balanced and evidence-based understanding of the kidney function testing market.

Synthesizing Key Findings to Guide Future Decisions

The landscape of kidney function testing is defined by advancing technologies, shifting regulatory environments, and evolving clinical priorities. From transformative assay platforms to region-specific dynamics, key insights highlight the importance of innovation, strategic partnerships, and operational agility. Tariff developments in the United States underscore the need for resilient supply chains, while segmentation analysis elucidates targeted pathways for product differentiation.

As market leaders continue to refine their portfolios and expand geographic reach, data-driven decision making will remain paramount. The recommendations and strategic considerations outlined in this summary provide actionable guidance to navigate emerging challenges and capture new opportunities. By synthesizing these findings, stakeholders are well positioned to shape the future direction of renal diagnostics and deliver enhanced patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Type
    • Blood Urea Nitrogen
    • Cystatin C
    • Glomerular Filtration Rate
    • Microalbuminuria
    • Serum Creatinine
  • Technology
    • Electrochemiluminescence
    • Fluorescence Polarization
    • Immunoassay
      • Clia
      • Elisa
      • Fia
    • Spectrophotometry
      • Colorimetric
      • Reflectance
  • End User
    • Diagnostic Laboratories
    • Home Care Settings
    • Hospitals
    • Kidney Care Clinics
  • Sample Type
    • Serum
    • Urine
  • Distribution Channel
    • Offline
    • Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Mindray Medical International Limited
  • Sekisui Medical Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Kidney Function Tests Market, by Test Type
8.1. Introduction
8.2. Blood Urea Nitrogen
8.3. Cystatin C
8.4. Glomerular Filtration Rate
8.5. Microalbuminuria
8.6. Serum Creatinine
9. Kidney Function Tests Market, by Technology
9.1. Introduction
9.2. Electrochemiluminescence
9.3. Fluorescence Polarization
9.4. Immunoassay
9.4.1. Clia
9.4.2. Elisa
9.4.3. Fia
9.5. Spectrophotometry
9.5.1. Colorimetric
9.5.2. Reflectance
10. Kidney Function Tests Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Home Care Settings
10.4. Hospitals
10.5. Kidney Care Clinics
11. Kidney Function Tests Market, by Sample Type
11.1. Introduction
11.2. Serum
11.3. Urine
12. Kidney Function Tests Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Americas Kidney Function Tests Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Kidney Function Tests Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Kidney Function Tests Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Danaher Corporation
16.3.5. Becton, Dickinson and Company
16.3.6. Thermo Fisher Scientific Inc.
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. Sysmex Corporation
16.3.9. Mindray Medical International Limited
16.3.10. Sekisui Medical Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. KIDNEY FUNCTION TESTS MARKET MULTI-CURRENCY
FIGURE 2. KIDNEY FUNCTION TESTS MARKET MULTI-LANGUAGE
FIGURE 3. KIDNEY FUNCTION TESTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. KIDNEY FUNCTION TESTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. KIDNEY FUNCTION TESTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. KIDNEY FUNCTION TESTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY BLOOD UREA NITROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY CYSTATIN C, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY GLOMERULAR FILTRATION RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY MICROALBUMINURIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY SERUM CREATININE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY ELECTROCHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY FLUORESCENCE POLARIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY CLIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY FIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY REFLECTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY KIDNEY CARE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL KIDNEY FUNCTION TESTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES KIDNEY FUNCTION TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. CANADA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. CANADA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 54. CANADA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 55. CANADA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. MEXICO KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. MEXICO KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 61. MEXICO KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 62. MEXICO KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. MEXICO KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. GERMANY KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 97. GERMANY KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 98. GERMANY KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. GERMANY KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 100. GERMANY KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. FRANCE KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. FRANCE KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 104. FRANCE KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 105. FRANCE KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. FRANCE KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 107. FRANCE KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. ITALY KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 116. ITALY KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. ITALY KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 118. ITALY KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 119. ITALY KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. ITALY KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 121. ITALY KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SPAIN KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. SPAIN KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 125. SPAIN KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 126. SPAIN KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. DENMARK KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 151. DENMARK KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. DENMARK KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. QATAR KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 165. QATAR KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. QATAR KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 167. QATAR KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 168. QATAR KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. QATAR KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 170. QATAR KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. FINLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. FINLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 174. FINLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 175. FINLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FINLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 177. FINLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. EGYPT KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. EGYPT KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 195. EGYPT KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 196. EGYPT KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. EGYPT KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 198. EGYPT KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. TURKEY KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 200. TURKEY KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. TURKEY KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 202. TURKEY KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 203. TURKEY KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. TURKEY KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 205. TURKEY KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NORWAY KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. NORWAY KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 216. NORWAY KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 217. NORWAY KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. NORWAY KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 219. NORWAY KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. POLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 221. POLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. POLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 223. POLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 224. POLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. POLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 226. POLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC KIDNEY FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 242. CHINA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 243. CHINA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. CHINA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 245. CHINA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 246. CHINA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. CHINA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 248. CHINA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. INDIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 250. INDIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. INDIA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 252. INDIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 253. INDIA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. INDIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 255. INDIA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. JAPAN KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. JAPAN KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 259. JAPAN KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 260. JAPAN KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. JAPAN KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 262. JAPAN KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. THAILAND KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. THAILAND KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 287. THAILAND KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 288. THAILAND KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. THAILAND KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 290. THAILAND KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN KIDNEY FUNCTION TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN KIDNEY FUNCTION TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN KIDNEY FUNCTION TESTS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN KIDNEY FUNCTION TESTS MARKET SIZE, BY SPECTROPHOTOMETRY, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN KIDNEY FUNCTION TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN KIDNEY FUNCTION TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN KIDNEY FUNCTION TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. KIDNEY FUNCTION TESTS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 327. KIDNEY FUNCTION TESTS MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Kidney Function Tests market report include:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Mindray Medical International Limited
  • Sekisui Medical Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.02 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.39 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Kidney Function Tests Market Size, Share & Trends Analysis Report By Product (Clearance Tests, Urine Tests, Blood Tests), By End Use (Hospitals, Diagnostic Laboratories, Research Laboratories And Institutes), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Kidney Function Tests Market Size, Share & Trends Analysis Report By Product (Clearance Tests, Urine Tests, Blood Tests), By End Use (Hospitals, Diagnostic Laboratories, Research Laboratories And Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Kidney Function Tests - Global Strategic Business Report - Product Image

Kidney Function Tests - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Kidney Function Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Kidney Function Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Kidney Function Tests Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Kidney Function Tests Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Renal Function Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Renal Function Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 206 Pages
  • Global
From

About the Kidney Function Test Market

The Kidney Function Test market within the In Vitro Diagnostics sector is focused on the development and production of tests that measure the performance of the kidneys. These tests are used to detect and diagnose kidney diseases, as well as to monitor the progress of treatment. Tests may measure the levels of creatinine, urea, electrolytes, and other substances in the blood or urine. They may also measure the glomerular filtration rate, which is an indicator of kidney function. The Kidney Function Test market is driven by the increasing prevalence of kidney diseases, as well as the need for early diagnosis and treatment. The market is also supported by advances in technology, such as automated testing systems, which have improved the accuracy and speed of testing. Some companies in the Kidney Function Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.